Abstract
European Journal of HaematologyVolume 73, Issue 5 p. 384-385 Evan's syndrome complicating multicentric Castleman's disease – dramatic response to rituximab J. P. Quinn, J. P. Quinn Departments of HaematologySearch for more papers by this authorO. M. Gilligan, O. M. Gilligan Departments of HaematologySearch for more papers by this authorM. Horgan, M. Horgan Infectious Diseases, Cork University Hospital, Cork City, IrelandSearch for more papers by this author J. P. Quinn, J. P. Quinn Departments of HaematologySearch for more papers by this authorO. M. Gilligan, O. M. Gilligan Departments of HaematologySearch for more papers by this authorM. Horgan, M. Horgan Infectious Diseases, Cork University Hospital, Cork City, IrelandSearch for more papers by this author First published: 30 September 2004 https://doi.org/10.1111/j.1600-0609.2004.00302.xCitations: 10 Dr John Quinn, Department of Haematology, Cork University Hospital, Cork City, Ireland Tel: 087-989-5049 Fax: 021-434-8037 e-mail: jpmquinn@hotmail.com Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume73, Issue5November 2004Pages 384-385 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
